新薬展望2018 第II部 注目の新薬〔持続性選択H 1 受容体拮抗・アレルギー性疾患治療剤〕一般名:デスロラタジン「デザレックス錠5mg」
2018
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
Old Web
English
Sign In
Email Address
acemap@cs.sjtu.edu.cn
- CCF Conference Analysis
- Map Galaxy
- Academic Report
- What's New
© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.